Wateya "Paqij" çi ye?
Heywan mutasyon hilnagire. Wê nexweşî pêş nekeve û wê derbas neke.
Discover the importance of the DNA test for Bernard-Soulier Syndrome (BSS-C) in dogs, a rare genetic disorder affecting platelet function and blood clotting. Early detection through this specialized DNA test helps breeders and veterinarians identify carriers and affected dogs, preventing the spread of BSS-C in breeding lines. By understanding your dog's genetic status, you can make informed decisions to ensure healthier litters and improve overall canine health. Our accurate and reliable Bernard-Soulier Syndrome DNA test offers peace of mind for responsible dog owners. Protect your dog's future with advanced genetic screening today. Stay proactive in managing hereditary conditions with our expert testing services.
Bernard-Soulier Syndrome (BSS-C) in dogs is a rare inherited bleeding disorder caused by a genetic mutation affecting platelet function. DNA testing can identify carriers and affected dogs by detecting mutations in the GP1b gene complex. Early diagnosis through genetic screening helps breeders avoid producing affected puppies. This test is crucial for managing the health of at-risk breeds. Understanding BSS-C at the DNA level supports better treatment and prevention strategies.
Ev testa DNA ji pakêta me dest pê dike tê de ye Basic - û di heman demê de beşek ji pakêtan e Basic, Standard, Advanced, Complete.
Pakêtên testa DNA-ê bibînin →Bernard-Soulier Syndrome (BSS-C) is a rare genetic disorder that affects blood clotting in dogs. This condition is characterized by a deficiency in the glycoprotein complex known as GPIb-IX-V, which plays a crucial role in platelet function and adhesion. As a result, dogs with BSS-C experience abnormal bleeding due to their platelets' inability to effectively bind to blood vessel walls, leading to a compromised hemostatic response.
BSS-C is inherited in an autosomal recessive manner, meaning that both copies of the gene involved must be mutated for the disease to manifest. The specific genetic mutations associated with BSS-C can be identified through DNA testing, allowing for the detection of carriers and affected individuals. Understanding the genetic basis of this condition is essential for breeding programs aimed at reducing the prevalence of BSS-C in canine populations.
Dogs affected by BSS-C may display various clinical signs that are primarily related to bleeding disorders. Common symptoms include prolonged bleeding from cuts or surgical sites, spontaneous nosebleeds, and the presence of bruises or petechiae (small red or purple spots on the skin). In more severe cases, internal bleeding can occur, which may lead to serious health complications. Early recognition and management of these symptoms are crucial for the welfare of affected dogs.
Diagnosis of Bernard-Soulier Syndrome typically involves a combination of clinical evaluation and laboratory testing. A veterinarian may observe the clinical signs and recommend blood tests to assess platelet function and count. Furthermore, DNA testing can confirm the diagnosis by identifying mutations in the genes associated with the syndrome. This comprehensive approach ensures accurate identification of the condition and aids in appropriate management strategies.
While there is no cure for Bernard-Soulier Syndrome, management strategies can help mitigate the risks associated with the condition. Supportive care may include avoiding situations that could lead to injury or bleeding. In cases of significant bleeding, veterinary intervention may be necessary, which can include blood transfusions or other therapeutic measures to stabilize the dog’s condition. Regular veterinary check-ups and monitoring are essential for managing the health of affected dogs.
Bernard-Soulier Syndrome is a significant genetic disorder that affects the hemostatic function in dogs, leading to a predisposition to bleeding. Through DNA testing, early diagnosis and management can be achieved, improving the quality of life for affected individuals. Awareness and understanding of this condition are vital for dog owners, breeders, and veterinarians alike.
Heywan mutasyon hilnagire. Wê nexweşî pêş nekeve û wê derbas neke.
Naxêr. Ajal bi gelemperî saxlem e lê dikare mutasyonê bigihîne xwe dûndana.
Ew du kopiyên mutated digire. Nîşanên klînîkî li gorî têne hêvî kirin nexweşî. Divê ew neyê çandin.
Hin nexweşî bi zayendî ve girêdayî ne, ji ber vê yekê vegotina wan li gorî nexweşiyê diguhere zayenda heywanan.
This DNA test detects the mutation associated with Bernard-Soulier Syndrome (BSS-C) in order to identify clear, carrier, or at-risk animals.
Testkirina DNA ji cotkaran re dibe alîkar ku zewacên bi ewletir plansaz bikin û xetera veguheztina mutasyonê ji nifşan re kêm bikin.
Moda mîrasê ya ku ji bo vê ceribandinê hatî ragihandin Autosomal Recessive ye.
This test analyses the mutation GP9 c.127_*2052del.
Ne hewce ye. Şîrovekirin bi şêwaza mîras û genotipa encam ve girêdayî ye.
Gentilini Fabio, Turba Maria Elena, Giancola Fiorella, Chiocchetti Roberto, Bernardini Chiara, Dajbychova Markéta, Jagannathan Vidhya, Drögemüller Michaela, Drögemüller Cord. A large deletion in the GP9 gene in Cocker Spaniel dogs with Bernard-Soulier syndrome. PLoS One. 2019 Sep 4;14(9):e0220625. doi: 10.1371/journal.pone.0220625. eCollection 2019.
Nepeniya we, hilbijartina we
Em çerezên bingehîn bikar tînin da ku malperê bimeşînin. Kokiyên bijarte (wek pêşkêşkerên naverokê yên bicîbûyî) ji hêla xwerû ve têne neçalak kirin û tenê heke hûn razî bibin têne çalak kirin. Hûn dikarin bijartina xwe her dem bi karanîna bişkoka "Cookies" biguhezînin.
Ji bo taybetmendiyên bingehîn û ewlehiyê pêdivî ye. Her tim çalak.
Taybetmendiyên mîna hilanîna tercihê an ne-reklamê bicîh dike.
Alîkariya me dike ku karanîna malperê fam bikin. Ji hêla xwerû ve neçalak kirin.
Reklam/şopandina li ser malperan (hin vîdyo/nexşe hatine bicîkirin). Ji hêla xwerû ve neçalak kirin.